Viewing nowCombinationTelastar Tablet 40/10 mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Aprogen Biologics Co., Ltd.

MFDS item code 201606333 · Approved 2016.10.28 · Insurance code 645209290
Treatment of essential hypertension not controlled with monotherapy
This medicine is used for patients with essential hypertension who have difficulty controlling blood pressure with either amlodipine or telmisartan alone. It helps effectively lower blood pressure, allowing for stable management of blood pressure and reducing the risk of cardiovascular diseases. Therefore, this medication is used for blood pressure control in essential hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this medicine; however, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when receiving this medicine’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
○ Pediatric patients: The administration of this medicine is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This medication can pose serious risks to the fetus, particularly during the second and third trimesters of pregnancy, and should not be taken by pregnant women or women who may become pregnant. This medication should not be administered to patients with certain conditions, such as liver impairment, heart issues, severe hypotension, or severely compromised kidney function. Additionally, patients with primary aldosteronism, certain heart valve diseases, liver problems, or gastrointestinal disorders should use this drug with caution. Elderly patients and those with impaired kidney function also require caution when taking this medication. Various side effects may occur, such as dizziness, peripheral edema, palpitations, hypotension, and dyspepsia, so medical consultation should be sought immediately if symptoms appear. Regular blood tests and monitoring are important due to the risk of excessively low blood pressure or elevated potassium levels. Furthermore, interactions may occur if this medication is taken with certain other drugs, so the healthcare provider must be informed if other medications are being used. It is also advisable for breastfeeding women to avoid this medication, and safety and efficacy have not been established for pediatric patients. In case of overdose, serious hypotension or cardiac issues may occur, requiring immediate emergency treatment. This medication should be kept out of reach of children and stored in its original packaging.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a special container that blocks light. Additionally, it is important to store it at room temperature, between 1°C and 30°C, to maintain its efficacy.
White to light yellow and light blue, oval biconvex double-coated tablets
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Aprogen Biologics Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.